In a world first, Queensland-based TGA licensed medical device manufacturer Melcare Biomedical, has announced the results of research undertaken by Queensland University of Technology (QUT) into the use of its Optimel™ Manuka honey product range for the treatment of Meibomian Gland Dysfunction (MGD) induced dry eye and related dry eye conditions.
You can read the full article here.
